OverviewThe global NLP in healthcare and life sciences market is witnessing rapid expansion and is expected to grow at an ...

Grants totalling in excess of £2.2M awarded from two industry leading innovation fundsThe new grants will support the development of Laverock’s single-cell and AI powered gene-control platform, ...

Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a broad population of people living with ...

Pesticides. Mycotoxins. Fraudulent Lab Reports. Forged Certificates of Analysis. This Is the State-Licensed Cannabis and Hemp Supply Chain the Courts and DEA Just Handed a Federal Registration Pathway ...

Camzyos has the potential to be the first pharmacological therapy for the treatment of oHCM in adolescents, addressing a high unmet need for this populationApplication based on positive results of ...

Synexis®, LLC, the leader in touchless, continuous pathogen control technology, today announced a strategic collaboration with Midwest Veterinary Supply to bring Synexis DHP® technology to animal ...

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to ...

Nature-Cide X2 Plus Selected as Preferred All-Natural SolutionAs Customer Demand Trends Toward Natural Pest Control Solutions, Mosquito Authority / Pest Authority Launches Company-Wide Initiative to ...

Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing ...

The Poison Pill defends against no legitimate threat; 3D's acquisition of additional shares is not aimed at seizing ...

The global hemodynamic monitoring systems market is projected to witness steady growth during the forecast period, expanding ...

Likozam® will be reimbursed to patients starting June 12, 2026 Official reimbursement ends the “Early Access” clawbackThe ...